Kennedy Capital Management’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.63M | Sell |
686,968
-546,446
| -44% | -$2.09M | 0.06% | 398 |
|
|
2025
Q1 | $7.09M | Sell |
1,233,414
-235,105
| -16% | -$1.35M | 0.17% | 212 |
|
|
2024
Q4 | $7.33M | Sell |
1,468,519
-412,559
| -22% | -$2.06M | 0.16% | 218 |
|
|
2024
Q3 | $10.1M | Buy |
1,881,078
+281,405
| +18% | +$1.52M | 0.22% | 138 |
|
|
2024
Q2 | $5.29M | Buy |
1,599,673
+281,518
| +21% | +$932K | 0.11% | 306 |
|
|
2024
Q1 | $4.31M | Buy |
1,318,155
+42,009
| +3% | +$137K | 0.09% | 355 |
|
|
2023
Q4 | $4.48M | Buy |
+1,276,146
| New | +$4.48M | 0.1% | 325 |
|